Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Ronshine China Holdings $200 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares
Guorui Properties exchange offer and consent solicitation
We advised the dealer manager on the transaction
Primavera Capital Acquisition $414 million IPO
We advised Primavera, a SPAC, on its IPO and NYSE listing
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
Ronshine China Holdings $300 million high-yield notes offering
We advised the initial purchaser on the Regulation S offering
RiseSun Real Estate Development $300 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Hopson Development $400 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
China South City Holdings $120 million high-yield notes reopening
We advised the initial purchasers on the Regulation S offering
Dexin China Holdings $150 million high-yield notes reopening
We advised the initial purchasers on the Regulation S offering